SynthesisJournal of the National Cancer Institute2020

A Systematic Review and Meta-Analysis of Bevacizumab in First-Line Metastatic Breast Cancer: Lessons for Research and Regulatory Enterprises.

Spencer Phillips Hey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.